Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer

Stopped Further understanding about the role of androgen signaling in TNBC was required

Conditions

• Breast Cancer

Interventions

• DRUG: Enzalutamide
• DRUG: Placebo
• DRUG: Paclitaxel

Sponsor

Pfizer

Collaborators

• [object Object]
• [object Object]